Question

A health care professional is caring for a patient who is about to begin taking ploglitazone (Actos) to treat type 2 diabetes mellitus. The health care professional should explain to the patient the need to monitor which of the following laboratory tests? (Select all that apply)

A. TSH
B. ALT
C. LDL
D. CBC
E Creatinine clearance

Answer 1

The healthcare professional should explain to the patient the need to monitor ALT, LDL, CBC, and creatinine clearance when taking pioglitazone to treat type 2 diabetes mellitus.

Step-by-step explanation:

The healthcare professional should explain to the patient who is about to begin taking pioglitazone (Actos) to treat type 2 diabetes mellitus the need to monitor the following laboratory tests:

• ALT (Alanine Aminotransferase): This test measures the level of ALT in the blood and helps monitor liver function as pioglitazone can cause liver damage.
• LDL (Low-Density Lipoprotein): This test measures the level of LDL cholesterol in the blood. Ploglitazone may cause an increase in LDL levels, so it is important to monitor and manage cholesterol levels.
• CBC (Complete Blood Count): This test measures different components of the blood, including red and white blood cells. Ploglitazone can cause anemia or changes in blood cell counts, so monitoring CBC is necessary.
• Creatinine clearance: This test assesses kidney function. Ploglitazone can affect the kidneys, so monitoring creatinine clearance helps detect any abnormalities.